Tag: Cardiovascular
United States Cardiovascular Needle Market Report 2022-2026 – Manufacturers are …...
The "The US Cardiovascular Needle Market: Analysis By Type, By Application, By Usage, By End User, Size and Trends with Impact of COVID-19...
The Cardiovascular Care Group Raises Awareness of Peripheral Artery Disease –...
SCOTCH PLAINS, N.J., March 19, 2022 /PRNewswire-PRWeb/ -- With 60 years of experience, The Cardiovascular Care Group is nationally recognized as the best...
Cardiovascular Proximal Anastomosis Devices Market to Reach US$ 23.6 Mn by...
ALBANY, N.Y., March 3, 2022...
How is High Prevalence of Cardiovascular Diseases Shaping Demand for Coronary...
As per Fact.MR – a market research and competitive intelligence provider, the global coronary microcatheters market was valued at around US$ 179 Mn in 2020,...
CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach,...
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of...
Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic...
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction...
Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent...
Reimbursement dossiers for first 10 countries to be filed in coming months 150 people hired and on-track to be deployed by mid-Q2...
Amarin Receives European Commission (EC) Approval for VAZKEPA to Reduce Cardiovascular...
Marks first and only EC-approved treatment to reduce cardiovascular risk in high-risk, statin-treated adult patients who have elevated triglycerides (≥150 mg/dL) and other...